CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European...
Our managing director, Tim Phillips, has been invited to participate in the Professionally Cannabis Podcast, which is aimed towards entrepreneurs, connoisseurs and those interested in the science behind the...
Our managing director, Tim Phillips, discussed international CBD opportunities during the USA CBD Expo in Las Vegas in February. He examined cannabidiol developments and highlighted the number of companies and brands present in the market nowadays, along with...
As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides some analysis relating...
In Spain, as in other EU countries, interest in CBD has increased. However, market development is hampered by legal uncertainties and complexity – as our analyst Elsa Carrasco explains ...
Our host for today’s podcast is Lydia Thompson, editor at CBD-Intel, who will be joined by CBD-Intel regulatory and legal analyst Lenka Hajnovicova, who focuses on developments of hemp-based products in Europe, the Middle East, and Latin America...
Our host for today’s podcast is Tim Phillips, the founder and managing director of CBD-Intel, who presents a CBD year overview and analysis of the regulatory path in the sector ...
Our host for today’s podcast is Lydia Thompson, editor at CBD-Intel, who will be joined by CBD-Intel market analyst Maria Alejandra Estanga, who focuses on the CBD market for countries in Europe and the Americas ...
Our host for today’s podcast is Pablo Cano Trilla, CBD’s head of legal analysis, who leads our international, US and EU coverage in regulatory reports and trackers. Pablo is a qualified attorney, specialised in international law, EU law...
Our host for today’s podcast is Berta Camps-Bisbal, CBD-Intel’s US regulatory analyst, responsible for tracking all US federal, state and local regulations. In this episode, Berta talks about the hemp regulatory environment in the US and covers the...
Our host for today’s podcast is Lydia Thompson, editor at CBD-Intel, who will be joined by CBD-Intel senior regulatory analyst Marija Obradovic. Marija is focused on legal and policy analysis of CBD and cannabis-based consumer products. The discussion...
CBD-Intel’s regular podcasts provide expert insight into global regulation, market trends and the latest developments. Join us to find out more about this fast-moving industry with the CBD-Intel team. Thanks for...
CBD-Intel would like to thank Anuj Desai of The Cannabis Conversation for inviting our managing director, Tim Phillips, to take part in this podcast, which explores the legal cannabis industry through a European perspective. In this conversation, Tim...
The All New Cannabis Show is an elevated conversation that provides listeners with the latest information and advice about CBD health and wellness products, as well as the business of cannabis and hemp derivatives. In this episode, CBD-Intel has...
Vitafood Insights invited CBD-Intel to participate in one of their podcast sessions to offer a comprehensive understanding of the regulatory landscape of CBD in Europe. CBD is dominating worldwide attention and it is essential for companies looking to...
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
